{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T16:20:57Z","timestamp":1774974057405,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100015650","name":"Canon Medical Systems Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015650","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004330","name":"Smoking Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol Exp"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>We compared the capabilities of quantitatively assessed paired inspiratory-expiratory area-detector computed tomography (ADCT) for pulmonary functional loss and disease severity evaluations between upright and supine ADCT in matched progressive pulmonary fibrosis (PPF) patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>\n                      This retrospective cohort consisted of age-, sex-, and underlying disease-matched patients with PPF who underwent paired inspiratory-expiratory CT on upright ADCT (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200940) and supine ADCT (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200940), pulmonary function tests, and disease severity assessment. Based on CT data, the absolute values of the logarithm of the Jacobian determinant and warp-field magnitude of the whole lung and all lobes were calculated. Stepwise regression analyses were performed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      On supine ADCT, both indices of the left lower lobe (LLL) were the first and only steps for pulmonary function test results and CT-assessed disease severity (absolute value of the logarithm of the Jacobian determinant: 0.139 \u2264\n                      <jats:italic>r<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2264 0.175, 0.007 \u2264\n                      <jats:italic>p<\/jats:italic>\n                      \u2009\u2264\u20090.018; absolute value of the warp-field magnitude: 0.371 \u2264\n                      <jats:italic>r<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2264 0.447,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). However, on upright ADCT, both indices indicated that LLL was the first step and the right lower lobe was the second step for pulmonary function test results and CT-assessed disease severity (0.503 \u2264\n                      <jats:italic>r<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2264 0.674,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001 or 0.000 &lt;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009\u2264\u20090.006 and 0.474 \u2264\n                      <jats:italic>r<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      \u2264 0.652, 0.002 \u2264\n                      <jats:italic>p<\/jats:italic>\n                      \u2009\u2264\u20090.045, respectively).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Upright ADCT has equal to or better potential than supine ADCT for detecting pulmonary functional loss and evaluating disease severity when paired inspiratory-expiratory ADCT is applied in PPF patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Relevance statement<\/jats:title>\n                    <jats:p>Upright ADCT has superior potential to supine ADCT for pulmonary functional loss and disease severity evaluations when paired inspiratory-expiratory ADCT is performed in patients with progressive pulmonary fibrosis (PPF).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>Matched progressive pulmonary fibrosis patients compared functional loss and disease severity evaluations between inspiratory-expiratory upright and supine area-detector CT.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Clinical parameters demonstrated better correlations with upright than with supine inspiratory-expiratory area-detector CT.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Warp-field magnitude showed better correlations with disease severities than the logarithm of the Jacobian determinant on each area-detector CT.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s41747-026-00698-y","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T14:24:50Z","timestamp":1774967090000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of biomechanical assessment between upright and supine inspiratory-expiratory area-detector CT in progressive pulmonary fibrosis"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4431-1084","authenticated-orcid":false,"given":"Yoshiharu","family":"Ohno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kota","family":"Aoyagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirona","family":"Kimata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichiro","family":"Araoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naruomi","family":"Akino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Takenaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Hoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekata","family":"Yasuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Horiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naozumi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyoshi","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"698_CR1","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S2213-2600(20)30355-6","volume":"8","author":"PM George","year":"2020","unstructured":"George PM, Spagnolo P, Kreuter M et al (2020) Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities. Lancet Respir Med 8:925\u2013934. https:\/\/doi.org\/10.1016\/S2213-2600(20)30355-6","journal-title":"Lancet Respir Med"},{"key":"698_CR2","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/S2213-2600(20)30355-6.10.1080\/03007995.2019.1647040","volume":"35","author":"M Wijsenbeek","year":"2019","unstructured":"Wijsenbeek M, Kreuter M, Olson A et al (2019) Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management. Curr Med Res Opin 35:2015\u20132024. https:\/\/doi.org\/10.1016\/S2213-2600(20)30355-6.10.1080\/03007995.2019.1647040","journal-title":"Curr Med Res Opin"},{"key":"698_CR3","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1056\/NEJMc2031135","volume":"383","author":"M Wijsenbeek","year":"2020","unstructured":"Wijsenbeek M, Cottin V (2020) Spectrum of fibrotic lung diseases. Reply. N Engl J Med 383:2485\u20132486. https:\/\/doi.org\/10.1056\/NEJMc2031135","journal-title":"N Engl J Med"},{"key":"698_CR4","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu G, Remy-Jardin M, Richeldi L et al (2022) Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med 205:e18\u2013e47. https:\/\/doi.org\/10.1164\/rccm.202202-0399ST","journal-title":"Am J Respir Crit Care Med"},{"key":"698_CR5","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","volume":"381","author":"KR Flaherty","year":"2019","unstructured":"Flaherty KR, Wells AU, Cottin V et al (2019) Nintedanib in progressive fibrosing interstitial lung diseases. N Engl J Med 381:1718\u20131727. https:\/\/doi.org\/10.1056\/NEJMoa1908681","journal-title":"N Engl J Med"},{"key":"698_CR6","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S2213-2600(20)30036-9","volume":"8","author":"AU Wells","year":"2020","unstructured":"Wells AU, Flaherty KR, Brown KK et al (2020) Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial. Lancet Respir Med 8:453\u2013460. https:\/\/doi.org\/10.1016\/S2213-2600(20)30036-9","journal-title":"Lancet Respir Med"},{"key":"698_CR7","doi-asserted-by":"publisher","first-page":"2004538","DOI":"10.1183\/13993003.04538-2020","volume":"59","author":"KR Flaherty","year":"2022","unstructured":"Flaherty KR, Wells AU, Cottin V et al (2022) Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trial. Eur Respir J 59:2004538. https:\/\/doi.org\/10.1183\/13993003.04538-2020","journal-title":"Eur Respir J"},{"key":"698_CR8","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1159\/000507265","volume":"99","author":"Y Yamada","year":"2020","unstructured":"Yamada Y, Yamada M, Yokoyama Y et al (2020) Differences in lung and lobe volumes between supine and standing positions scanned with conventional and newly developed 320-detector-row upright CT: intra-individual comparison. Respiration 99:598\u2013605. https:\/\/doi.org\/10.1159\/000507265","journal-title":"Respiration"},{"key":"698_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/RLI.0000000000000603","volume":"55","author":"M Jinzaki","year":"2020","unstructured":"Jinzaki M, Yamada Y, Nagura T et al (2020) Development of upright computed tomography with area detector for whole-body scans: phantom study, efficacy on workflow, effect of gravity on human body, and potential clinical impact. Invest Radiol 55:73\u201383. https:\/\/doi.org\/10.1097\/RLI.0000000000000603","journal-title":"Invest Radiol"},{"key":"698_CR10","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1159\/000527067","volume":"101","author":"Y Yamada","year":"2022","unstructured":"Yamada Y, Chubachi S, Yamada M et al (2022) Comparison of lung, lobe, and airway volumes between supine and upright computed tomography and their correlation with pulmonary function test in patients with chronic obstructive pulmonary disease. Respiration 101:1110\u20131120. https:\/\/doi.org\/10.1159\/000527067","journal-title":"Respiration"},{"key":"698_CR11","doi-asserted-by":"publisher","unstructured":"No authors (1987) Standardization of spirometry\u20121987 update. Statement of the American Thoracic Society. Am Rev Respir Dis 136:1285\u20121298. https:\/\/doi.org\/10.1164\/ajrccm\/136.5.1285","DOI":"10.1164\/ajrccm\/136.5.1285"},{"key":"698_CR12","doi-asserted-by":"publisher","unstructured":"No authors (1995) Standardization of spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med 152:1107\u20121136. https:\/\/doi.org\/10.1164\/ajrccm.152.3.7663792","DOI":"10.1164\/ajrccm.152.3.7663792"},{"key":"698_CR13","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","volume":"200","author":"BL Graham","year":"2019","unstructured":"Graham BL, Steenbruggen I, Miller MR et al (2019) Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society technical statement. Am J Respir Crit Care Med 200:e70\u2013e88. https:\/\/doi.org\/10.1164\/rccm.201908-1590ST","journal-title":"Am J Respir Crit Care Med"},{"key":"698_CR14","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/978-3-540-45087-0_32","volume":"18","author":"WR Crum","year":"2003","unstructured":"Crum WR, Hill DL, Hawkes DJ (2003) Information theoretic similarity measures in non-rigid registration. Inf Process Med Imaging 18:378\u2013387. https:\/\/doi.org\/10.1007\/978-3-540-45087-0_32","journal-title":"Inf Process Med Imaging"},{"key":"698_CR15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/s1361-8415(98)80022-4","volume":"2","author":"JP Thirion","year":"1998","unstructured":"Thirion JP (1998) Image matching as a diffusion process: an analogy with Maxwell\u2019s demons. Med Image Anal 2:243\u2013260. https:\/\/doi.org\/10.1016\/s1361-8415(98)80022-4","journal-title":"Med Image Anal"},{"key":"698_CR16","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1378\/chest.06-1401","volume":"131","author":"G Camiciottoli","year":"2007","unstructured":"Camiciottoli G, Orlandi I, Bartolucci M et al (2007) Lung CT densitometry in systemic sclerosis: correlation with lung function, exercise testing, and quality of life. Chest 131:672\u2013681. https:\/\/doi.org\/10.1378\/chest.06-1401","journal-title":"Chest"},{"key":"698_CR17","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/jmri.21550","volume":"28","author":"Y Ohno","year":"2008","unstructured":"Ohno Y, Koyama H, Nogami M et al (2008) Dynamic perfusion MRI: capability for evaluation of disease severity and progression of pulmonary arterial hypertension in patients with connective tissue disease. J Magn Reson Imaging 28:887\u2013899. https:\/\/doi.org\/10.1002\/jmri.21550","journal-title":"J Magn Reson Imaging"},{"key":"698_CR18","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.ejrad.2013.02.031","volume":"82","author":"Y Ohno","year":"2013","unstructured":"Ohno Y, Nishio M, Koyama H et al (2013) Pulmonary MR imaging with ultra-short TEs: utility for disease severity assessment of connective tissue disease patients. Eur J Radiol 82:1359\u20131365. https:\/\/doi.org\/10.1016\/j.ejrad.2013.02.031","journal-title":"Eur J Radiol"},{"key":"698_CR19","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.ejrad.2013.11.001","volume":"83","author":"Y Ohno","year":"2014","unstructured":"Ohno Y, Nishio M, Koyama H et al (2014) Oxygen-enhanced MRI for patients with connective tissue diseases: comparison with thin-section CT of capability for pulmonary functional and disease severity assessment. Eur J Radiol 83:391\u2013397. https:\/\/doi.org\/10.1016\/j.ejrad.2013.11.001","journal-title":"Eur J Radiol"},{"key":"698_CR20","first-page":"614","volume":"44","author":"YH Chan","year":"2003","unstructured":"Chan YH (2003) Biostatistics 104: correlational analysis. Singapore Med J 44:614\u2013619","journal-title":"Singapore Med J"},{"key":"698_CR21","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant 48:452\u2013458. https:\/\/doi.org\/10.1038\/bmt.2012.244","journal-title":"Bone Marrow Transplant"},{"key":"698_CR22","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.trsl.2012.01.012","volume":"159","author":"R Vij","year":"2012","unstructured":"Vij R, Noth I (2012) Peripheral blood biomarkers in idiopathic pulmonary fibrosis. Transl Res 159:218\u2013227. https:\/\/doi.org\/10.1016\/j.trsl.2012.01.012","journal-title":"Transl Res"},{"key":"698_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1471-2466-12-55","volume":"12","author":"T Samukawa","year":"2012","unstructured":"Samukawa T, Hamada T, Uto H et al (2012) The elevation of serum napsin A in idiopathic pulmonary fibrosis, compared with KL-6, surfactant protein-A and surfactant protein-D. BMC Pulm Med 12:55. https:\/\/doi.org\/10.1186\/1471-2466-12-55","journal-title":"BMC Pulm Med"},{"key":"698_CR24","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/resp.12500","volume":"20","author":"M Nakayama","year":"2015","unstructured":"Nakayama M, Bando M, Araki K et al (2015) Physical activity in patients with idiopathic pulmonary fibrosis. Respirology 20:640\u2013646. https:\/\/doi.org\/10.1111\/resp.12500","journal-title":"Respirology"},{"key":"698_CR25","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1159\/000503689","volume":"98","author":"M Xue","year":"2019","unstructured":"Xue M, Guo Z, Cai C, Sun B, Wang H (2019) Evaluation of the diagnostic efficacies of serological markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in idiopathic interstitial pneumonia. Respiration 98:534\u2013545. https:\/\/doi.org\/10.1159\/000503689","journal-title":"Respiration"},{"key":"698_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12890-020-1060-y","volume":"20","author":"T Yoshikawa","year":"2020","unstructured":"Yoshikawa T, Otsuka M, Chiba H et al (2020) Surfactant protein A as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosis. BMC Pulm Med 20:27. https:\/\/doi.org\/10.1186\/s12890-020-1060-y","journal-title":"BMC Pulm Med"},{"key":"698_CR27","doi-asserted-by":"publisher","first-page":"e2024015","DOI":"10.36141\/svdld.v41i2.15454","volume":"41","author":"A Kay\u0131k\u00e7\u0131","year":"2024","unstructured":"Kay\u0131k\u00e7\u0131 A, Alatas F, Alatas IO, Y\u0131ld\u0131r\u0131m H, Ozen H (2024) The role of biomarkers in the diagnosis and treatment follow-up of idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 41:e2024015. https:\/\/doi.org\/10.36141\/svdld.v41i2.15454","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"698_CR28","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.diii.2020.09.001","volume":"101","author":"M Benchoufi","year":"2020","unstructured":"Benchoufi M, Matzner-Lober E, Molinari N, Jannot AS, Soyer P (2020) Interobserver agreement issues in radiology. Diagn Interv Imaging 101:639\u2013641. https:\/\/doi.org\/10.1016\/j.diii.2020.09.001","journal-title":"Diagn Interv Imaging"},{"key":"698_CR29","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1378\/chest.07-2444","volume":"134","author":"JG Goldin","year":"2008","unstructured":"Goldin JG, Lynch DA, Strollo DC et al (2008) High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease. Chest 134:358\u2013367. https:\/\/doi.org\/10.1378\/chest.07-2444","journal-title":"Chest"},{"key":"698_CR30","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","volume":"177","author":"NS Goh","year":"2008","unstructured":"Goh NS, Desai SR, Veeraraghavan S et al (2008) Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med 177:1248\u20131254. https:\/\/doi.org\/10.1164\/rccm.200706-877OC","journal-title":"Am J Respir Crit Care Med"},{"key":"698_CR31","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1136\/thoraxjnl-2013-203843","volume":"69","author":"SL Walsh","year":"2014","unstructured":"Walsh SL, Sverzellati N, Devaraj A, Keir GJ, Wells AU, Hansell DM (2014) Connective tissue disease related fibrotic lung disease: high resolution computed tomographic and pulmonary function indices as prognostic determinants. Thorax 69:216\u2013222. https:\/\/doi.org\/10.1136\/thoraxjnl-2013-203843","journal-title":"Thorax"},{"key":"698_CR32","doi-asserted-by":"publisher","first-page":"E453","DOI":"10.5489\/cuaj.5186","volume":"12","author":"M Abdulaziz","year":"2018","unstructured":"Abdulaziz M, Kavanagh A, Stothers L, Macnab AJ (2018) Relevance of open magnetic resonance imaging position (sitting and standing) to quantify pelvic organ prolapse in women. Can Urol Assoc J 12:E453\u2013E460. https:\/\/doi.org\/10.5489\/cuaj.5186","journal-title":"Can Urol Assoc J"},{"key":"698_CR33","doi-asserted-by":"publisher","first-page":"E20","DOI":"10.5489\/cuaj.7244","volume":"16","author":"L Stothers","year":"2022","unstructured":"Stothers L, Locke JA, Abdulaziz M, Lazare D, Kavanagh A, Macnab A (2022) Standing open magnetic resonance imaging improves detection and staging of pelvic organ prolapse. Can Urol Assoc J 16:E20\u2013E24. https:\/\/doi.org\/10.5489\/cuaj.7244","journal-title":"Can Urol Assoc J"},{"key":"698_CR34","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s41747-025-00593-y","volume":"9","author":"FT Gassert","year":"2025","unstructured":"Gassert FT, Heuchert J, Schick R et al (2025) Lung volume assessment for mean dark-field coefficient calculation using different determination methods. Eur Radiol Exp 9:53. https:\/\/doi.org\/10.1186\/s41747-025-00593-y","journal-title":"Eur Radiol Exp"},{"key":"698_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-07985-5","volume":"15","author":"Y Wang","year":"2025","unstructured":"Wang Y, Ke S, Li J et al (2025) Assessing morphological changes in the choroid plexus between standing and supine positions using a rotatable MRI system. Sci Rep 15:22329. https:\/\/doi.org\/10.1038\/s41598-025-07985-5","journal-title":"Sci Rep"}],"container-title":["European Radiology Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41747-026-00698-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41747-026-00698-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41747-026-00698-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T14:24:51Z","timestamp":1774967091000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41747-026-00698-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["698"],"URL":"https:\/\/doi.org\/10.1186\/s41747-026-00698-y","relation":{},"ISSN":["2509-9280"],"issn-type":[{"value":"2509-9280","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"22 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the institutional review board of Fujita Health University Hospital (HM20-603) on May 19, 2021. This study was also compliant with the Health Insurance Portability and Accountability Act, which waived the requirement for written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"This study was also compliant with the Health Insurance Portability and Accountability Act, which waived the requirement for written informed consent. Informed consent was obtained in the form of opt-out on the website. Those who rejected were excluded.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This study was financially and technically supported by Canon Medical Systems Corporation and financially supported by Smoking Research Foundation. Drs. Ohno and Nomura received a research grant from Canon Medical Systems Corporation, which also supported this work technically. Drs. Ohno and Ozawa also received research grants from the Smoking Research Foundation. Messer. Aoyagi, Ito, Fujii, Araoka, and Akino and Ms. Kimata are employees of Canon Medical Systems Corporation. Furthermore, all authors and our institution and department chair, Prof. Yoshiharu Ohno, who is the corresponding author, agree to the publication of this report. This information is stated in the main text. Prof. Yoshiharu Ohno, the first and corresponding author, is Professor and Chairman of Diagnostic Radiology in Fujita Health University School of Medicine. All authors and the institution, as well as department chair, Prof. Yoshiharu Ohno, agree to publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}